Used primarily in pharmaceutical research and development, this compound exhibits potential as a selective serotonin reuptake inhibitor (SSRI) or modulator of central nervous system activity. Its structure supports interaction with neurotransmitter receptors, making it a candidate for treating mood disorders such as depression and anxiety. The presence of aromatic and ether functionalities enhances blood-brain barrier penetration, improving central activity. Additionally, it may serve as an intermediate in synthesizing more complex bioactive molecules. Due to its dihydrochloride salt form, it offers improved solubility and stability, which are advantageous for formulation in preclinical studies.